Budget Impact Analysis of Treatment with Ultibro Breezhaler® Versus Seretide Diskus® 50/500 Μg for Moderate to Very Severe COPD Patients
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1525
https://www.valueinhealthjournal.com/article/S1098-3015(17)31859-4/fulltext
Title :
Budget Impact Analysis of Treatment with Ultibro Breezhaler® Versus Seretide Diskus® 50/500 Μg for Moderate to Very Severe COPD Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31859-4&doi=10.1016/j.jval.2017.08.1525
First page :
A652
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1378